The present invention is directed to compounds of Formula I: ##STR1##

and Formula II: ##STR2##

(where variables R1, R2, R3, R4, A, B, G, J, Q, T, U, V, W, X and Y are as defined herein) useful as antagonists of CGRP receptors and useful in the treatment or prevention of diseases in which the CGRP is involved, such as headache, migraine and cluster headache. The invention is also directed to pharmaceutical compositions comprising these compounds and the use of these compounds and compositions in the prevention or treatment of such diseases in which CGRP is involved.

 
Web www.patentalert.com

< Reservoir and a series of related reservoirs for use in an electrotransport drug delivery device and devices comprised thereof

< Small conductance, calcium-activated potassium channels (SK 3)

> Methods of diagnosing and treating small intestinal bacterial overgrowth (SIBO) and SIBO-related conditions

> Compositions and methods for identifying modulators of transducisomes, a new class of therapeutic targets

~ 00214